Literature DB >> 17086617

Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.

Przemyslaw J Kotyla, Bogna Sliwinska-Kotyla, Eugene J Kucharz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17086617

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  8 in total

Review 1.  Current and novel therapeutics in the treatment of systemic lupus erythematosus.

Authors:  Cagri Yildirim-Toruner; Betty Diamond
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

2.  Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus.

Authors:  Przemyslaw J Kotyla
Journal:  Rheumatol Int       Date:  2008-08-23       Impact factor: 2.631

3.  The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology.

Authors:  Przemyslaw Kotyla
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

Review 4.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 5.  Potential use of statins in the treatment of antiphospholipid syndrome.

Authors:  Chary Lopez-Pedrera; Patricia Ruiz-Limon; M Angeles Aguirre; Antonio Rodriguez-Ariza; Maria José Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 6.  Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

Review 7.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

8.  Statin use and markers of immunity in the Doetinchem cohort study.

Authors:  Hilda J I De Jong; Jan G M C Damoiseaux; Rob J Vandebriel; Patrick C Souverein; Eric R Gremmer; Mia Wolfs; Olaf H Klungel; Henk Van Loveren; Jan Willem Cohen Tervaert; W M Monique Verschuren
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.